Prinocate Spot-on-Solution Small Cat & Ferrets 40/4mg (<4kg) Pack of 3

Prinocate Spot-on-Solution Small Cat & Ferrets 40/4mg (<4kg) Pack of 3 is designed for the effective management of mixed parasitic infections. Its powerful formula targets multiple parasites, providing peace of mind for pet owners.

Key Benefits of Prinocate Spot-on-Solution

• Comprehensive Flea Control: Treats and prevents flea infestations (Ctenocephalides felis), a common cause of itching and discomfort for your pet. It can also be used as part of a treatment strategy for flea allergy dermatitis (FAD).
• Effective Worm Treatment: Targets a variety of internal parasites including gastrointestinal nematodes (such as adult and larval stages of Toxocara cati and Ancylostoma tubaeforme), lungworms (Eucoleus aerophilus and Aelurostrongylus abstrusus), and even the eye worm Thelazia callipaeda. This helps to prevent and treat conditions related to worms.
• Mite Elimination: Provides effective treatment for ear mite infestations (Otodectes cynotis) and notoedric mange (Notoedres cati), relieving irritating symptoms and promoting healthier skin and ears.
• Heartworm Prevention: Essential for pets living in or travelling to heartworm endemic areas, Prinocate Spot-on-Solution helps prevent heartworm disease (Dirofilaria immitis).
• Easy to Administer: As a convenient spot-on solution, it's simple to apply directly to your pet's skin, ensuring they receive the full protective dose.

By choosing Prinocate Spot-on-Solution Small Cat & Ferrets 40/4mg (<4kg) Pack of 3, you're opting for a reliable and effective solution to keep your small cat or ferret free from a broad spectrum of parasites. Trust Weldricks Pharmacy for your pet's health and wellness needs.

For external use only (spot-on use).

Dosage schedule for cats:

The recommended minimum doses are 10 mg/kg bodyweight imidacloprid and 1.0 mg/kg bodyweight moxidectin, equivalent to 0.1 ml/kg bodyweight of the veterinary medicinal product.

The treatment schedule should be based on individual veterinary diagnosis and on the local epidemiological situation.

Administer in accordance with the following table:

Flea treatment and prevention (Ctenocephalides felis):

One treatment prevents future flea infestation for 4 weeks. Pre-existing pupae in the environment may emerge for 6 weeks or longer after treatment is initiated, depending upon climatic conditions. Therefore, it may be necessary to combine treatment with this veterinary medicinal product with environmental treatments aimed at breaking the flea life cycle in the surroundings. This can result in a more rapid reduction in the household flea population. The veterinary medicinal product should be administered at monthly intervals when used as part of a treatment strategy for flea allergy dermatitis.

Treatment of ear mite infestation (Otodectes cynotis):

A single dose of the veterinary medicinal product should be administered. A further veterinary examination 30 days after treatment is recommended as some animals may require a second treatment. Do not apply directly to the ear canal.

Treatment of notoedric mange (Notoedres cati):

A single dose of the veterinary medicinal product should be administered.

Treatment of the lungworm Eucoleus aerophilus (syn. Capillaria aerophila) (adults):

A single dose of the veterinary medicinal product should be administered.

Prevention of Aelurostrongylus abstrusus:

The veterinary medicinal product should be administered monthly.

Treatment of Aelurostrongylus abstrusus:

The veterinary medicinal product should be administered monthly for three consecutive months.

Treatment of the eye worm Thelazia callipaeda (adults):

A single dose of the veterinary medicinal product should be administered.

Heartworm prevention (Dirofilaria immitis):

Cats in areas endemic for heartworm, or those which have travelled to endemic areas, may be infected with adult heartworms. Therefore prior to treatment with the veterinary medicinal product, the advice provided in section 3.5 of the PIL should be considered.

For prevention of heartworm disease, the veterinary medicinal product must be applied at regular monthly intervals during the time of the year when mosquitoes (the intermediate hosts which carry and transmit heartworm larvae) are present. The veterinary medicinal product may be administered throughout the year or at least 1 month before the first expected exposure to mosquitoes. Treatment should continue at regular monthly intervals until 1 month after the last exposure to mosquitoes. To establish a treatment routine, it is recommended that the same day or date be used each month. When replacing another heartworm preventative veterinary medicinal product in a heartworm prevention programme, the first treatment with this veterinary medicinal product must be given within 1 month of the last dose of the former medication.

In non-endemic areas there should be no risk of cats having heartworm. Therefore they can be treated without special precautions.

Roundworm and hookworm treatment (Toxocara cati and Ancylostoma tubaeforme):

In areas endemic for heartworm, monthly treatment may significantly reduce the risk of re-infection caused by the respective roundworms and hookworms. In areas non-endemic for heartworm, the veterinary medicinal product can be used as part of a seasonal prevention programme against fleas and gastrointestinal nematodes.

Dosage schedule for ferrets:

One pipette of the veterinary medicinal product for use in small cats and ferrets (0.4 ml) should be administered per animal.

Do not exceed the recommended dose.

The treatment schedule should be based on the local epidemiological situation.

Method of administration:

1. Remove the pipette from its packaging. Hold the pipette in an upright position, twist and pull the cap off.
2. Turn the cap around and place the other end of the cap back on the pipette. Push and twist the cap to break the seal, then remove the cap from the pipette.
3. Part the coat on the animal's neck at the base of the skull until the skin is visible. Place the tip of the pipette onto the skin and squeeze the pipette several times to empty its contents completely and directly onto the skin in one spot. Avoid contact between the veterinary medicinal product and your fingers.

Application at the base of the skull will minimise the opportunity for the animal to lick the veterinary medicinal product. The veterinary medicinal product should only be applied to undamaged skin.

Contraindications:

• Do not use in kittens under 9 weeks of age.
• Do not use in cases of hypersensitivity to the active substances (imidacloprid, moxidectin) or to any of the excipients.
• For ferrets: Do not use the veterinary medicinal product for large cats (0.8 ml) or for dogs (any size). For dogs, the corresponding veterinary medicinal product must be used.
• Do not use on canaries.

Special Warnings:

• The veterinary medicinal product's efficacy has not been tested in ferrets weighing over 2 kg, so the duration of effect might be shorter in these animals.
• Brief contact of the animal with water on one or two occasions between monthly treatments is unlikely to significantly reduce efficacy. However, frequent shampooing or immersion of the animal in water after treatment may reduce efficacy.
• Parasite resistance to any particular class of anthelmintic may develop following frequent, repeated use. Therefore, use should be based on assessment of each individual case and local epidemiological information to limit future resistance selection.
• Use should be based on a confirmed diagnosis of mixed infection (or risk of infection where prevention applies).

Special Precautions for Use:

• The treatment of cats weighing less than 1 kg and ferrets weighing less than 0.8 kg should be based on a benefit-risk assessment by a veterinarian.
• There is limited experience with this product in sick and debilitated animals; use only based on a benefit-risk assessment for these animals.
• The veterinary medicinal product should only be applied to undamaged skin.
• Ensure the content of the pipette or applied dose does not come into contact with the eyes or mouth of the recipient and/or other animals.
• Do not allow recently treated animals to groom each other.
• For cats and ferrets living in or travelling to heartworm-endemic areas, monthly treatment is recommended. If a cat or ferret is over 6 months old, attempts should be made to check heartworm status before prophylactic treatment, as use in animals with adult heartworms may cause serious adverse effects, including death.
• In severe cases of Notoedres cati infestation, concomitant supportive treatment may be necessary as this veterinary medicinal product alone may not be sufficient to prevent death.
• Imidacloprid is toxic for birds, especially canaries.

Special Precautions for the Person Administering the Product:

• To prevent children from accessing pipettes, keep them in original packaging until ready for use and dispose of used pipettes immediately.
• Do not ingest. In case of accidental ingestion, seek medical advice immediately and show the package leaflet or label to the physician.
• People with known hypersensitivity to benzyl alcohol, imidacloprid, or moxidectin should administer the product with caution.
• In very rare cases, the product may cause skin sensitisation or transient skin reactions (e.g., numbness, irritation, or burning/tingling sensation) or respiratory irritation in sensitive individuals.
• If the veterinary medicinal product accidentally gets into eyes, flush thoroughly with water.
• Avoid contact with skin, eyes, or mouth. In case of accidental spillage onto skin, wash off immediately with soap and water.
• Wash hands thoroughly after use.
• If skin or eye symptoms persist, seek medical advice immediately and show the package leaflet or label to the physician.
• Do not eat, drink, or smoke during application.
• Treated animals should not be handled, especially by children, until the application site is dry. It is recommended to apply the product in the evening.
• Recently treated animals should not be allowed to sleep in the same bed as their owner, especially children.

Other Precautions:

• The solvent in the veterinary medicinal product may stain or damage certain materials (e.g., leather, fabrics, plastics, finished surfaces). Allow the application site to dry before contact with such materials.

Adverse Events:

• Rare (1 to 10 animals / 10,000 animals treated): Vomiting, application site greasy fur, application site erythema, hypersensitivity reaction. These signs usually disappear without further treatment.
• Very Rare (<1 animal / 10,000 animals treated, including isolated reports): Behavioural disorder (e.g., agitation, lethargy), inappetence, neurological signs. These are often transient and may occur if the animal licks the application site.
• Undetermined Frequency: Pruritus, hypersalivation (occurs if the animal licks the application site immediately after treatment; not a sign of intoxication and disappears within minutes). Correct application minimises licking.

Use during Pregnancy, Lactation or Lay:

• The safety of the veterinary medicinal product has not been established during pregnancy and lactation. Use only according to a benefit-risk assessment by the responsible veterinarian.

Interaction with other medicinal products and other forms of interaction:

• During treatment with this veterinary medicinal product, no other antiparasitic macrocyclic lactone should be administered.
• No interactions between this product and routinely used veterinary medicinal products or medical/surgical procedures have been observed.

• Active substances:
  • Imidacloprid 40 mg
  • Moxidectin 4 mg
• Excipients:
  • Benzyl Alcohol (E 1519) 329 mg
  • Propylene Carbonate
  • Butylhydroxytoluene (E 321) 0.4 mg
  • Trolamine

The solution is clear, slightly yellow to yellow or to brownish yellow.